Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 4:14 pm Purchase | 2025-03-31 | 13G | Surrozen, Inc. SRZN | Stonepine Capital Management LLC | 332,451 9.900% | 87,793 (+35.88%) | Filing History |
| 2025-05-14 4:12 pm Purchase | 2025-03-31 | 13G | OptiNose, Inc. OPTN | Stonepine Capital Management LLC | 788,647 7.800% | 199,990 (+33.97%) | Filing History |
| 2025-05-14 4:10 pm Sale | 2025-03-31 | 13G | Inovio Pharmaceuticals, Inc. INO | Stonepine Capital Management LLC | 1,434,997 3.800% | -481,669 (-25.13%) | Filing History |
| 2025-05-14 4:07 pm Sale | 2025-03-31 | 13G | CalciMedica, Inc. CALC | Stonepine Capital Management LLC | 628,672 4.600% | -113,029 (-15.24%) | Filing History |
| 2025-05-14 4:04 pm Sale | 2025-03-31 | 13G | Aprea Therapeutics, Inc. APRE | Stonepine Capital Management LLC | 239,416 4.300% | -46,979 (-16.40%) | Filing History |
| 2025-02-25 5:16 pm Purchase | 2025-02-13 | 13G | Edesa Biotech, Inc. EDSA | Stonepine Capital Management LLC | 693,551 9.900% | 693,551 (New Position) | Filing History |
| 2025-02-13 12:38 pm Purchase | 2024-12-31 | 13G | OptiNose, Inc. OPTN | Stonepine Capital Management LLC | 588,657 5.900% | 588,657 (New Position) | Filing History |
| 2025-02-13 12:32 pm Sale | 2024-12-31 | 13G | Verastem, Inc. VSTM | Stonepine Capital Management LLC | 2,203,333 4.800% | -440,287 (-16.65%) | Filing History |
| 2025-02-13 12:15 pm Sale | 2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Stonepine Capital Management LLC | 286,395 5.100% | -79,041 (-21.63%) | Filing History |
| 2025-02-13 12:07 pm Sale | 2024-12-31 | 13G | TELA Bio, Inc. TELA | Stonepine Capital Management LLC | 2,353,099 6.000% | -478,740 (-16.91%) | Filing History |
| 2024-12-23 8:08 pm Purchase | 2024-12-17 | 13G | Inovio Pharmaceuticals, Inc. INO | Stonepine Capital Management LLC | 1,916,666 5.200% | 1,916,666 (New Position) | Filing History |
| 2024-12-13 2:55 pm Purchase | 2024-12-06 | 13G | CalciMedica, Inc. CALC | Stonepine Capital Management LLC | 741,701 5.400% | 741,701 (New Position) | Filing History |
| 2024-11-20 5:21 pm Purchase | 2024-11-13 | 13G | OptiNose, Inc. OPTN | Stonepine Capital Management LLC | 544,975 5.400% | 544,975 (New Position) | Filing History |
| 2024-11-13 5:42 pm Purchase | 2024-09-30 | 13G | Surrozen, Inc. SRZN | Stonepine Capital Management LLC | 244,658 7.300% | 45,500 (+22.85%) | Filing History |
| 2024-11-13 5:39 pm Sale | 2024-09-30 | 13G | Verastem, Inc. VSTM | Stonepine Capital Management LLC | 2,643,620 6.400% | -23,046 (-0.86%) | Filing History |
| 2024-11-13 5:38 pm Sale | 2024-09-30 | 13G | Evolus, Inc. EOLS | Stonepine Capital Management LLC | 1,369,821 2.200% | -3,963,183 (-74.31%) | Filing History |
| 2024-11-13 5:36 pm Purchase | 2024-09-30 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management LLC | 626,862 9.990% | 61,378 (+10.85%) | Filing History |
| 2024-11-13 5:35 pm Unchanged | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | Stonepine Capital Management LLC | 372,797 9.990% | 0 (Unchanged) | Filing History |
| 2024-11-13 5:34 pm Purchase | 2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Stonepine Capital Management LLC | 307,229 9.990% | 307,229 (New Position) | Filing History |
| 2024-11-13 5:32 pm Sale | 2024-09-30 | 13G | CalciMedica, Inc. CALC | Stonepine Capital Management LLC | 0 0.000% | -1,045,204 (Position Closed) | Filing History |